Wird geladen...
Epigenetic Changes at the Birc5 Promoter Induced by YM155 in Synovial Sarcoma
YM155 is an anti-cancer therapy that has advanced into 11 different human clinical trials to treat various cancers. This apoptosis-inducing therapy indirectly affects the protein levels of survivin (gene: Birc5), but the molecular underpinnings of the mechanism remain largely unknown. Synovial sarco...
Gespeichert in:
| Veröffentlicht in: | J Clin Med |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6463023/ https://ncbi.nlm.nih.gov/pubmed/30909651 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8030408 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|